This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
and you are
between 18 and 60
years old
The phase for this study is not defined.
Show me locations

The purpose

The purpose of this study was to determine the most suitable effect-site concentration of remifentanil for the LMA insertion during inhaled induction with 8% sevoflurane in adults.

Provided treatments

  • Drug: Remifentanil 1
  • Drug: Control
  • Drug: Remifentanil 2

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01456299. The sponsor of the trial is Gachon University Gil Medical Center and it is looking for 102 volunteers for the current phase.
Official trial title:
Target-controlled Infusion of Remifentanil for Laryngeal Mask Airway Insertion During Sevoflurane Induction in Adults